Medidata Oncology Solutions

Medidata Oncology Solutions is a robust suite of technologies designed to optimize oncology clinical trials. Built on the Rave EDC platform, it offers a unified approach to managing trial data while addressing unique oncology challenges. The solutions integrate core applications such as eCOA, imaging, and Health Record Connect, ensuring seamless data flow, improved patient engagement, and enhanced regulatory compliance.

Key features include scalable infrastructure for trials of all sizes, cost-effective bundling, and automation tools that reduce cycle times and operational costs. The platform emphasizes data accuracy through unified data management, advanced analytics, and AI, providing actionable insights for sponsors and sites. Patient-centric innovations simplify participation, streamline data collection, and improve the end-user experience, reducing burden for both patients and research sites.

With over 25 years of oncology experience, Medidata has supported 9,000+ oncology trials and 4 million patients globally. The platform has contributed to 93% of oncology trials approved by the FDA in 2023, demonstrating its industry-leading position. Its focus on sustainability also reduces the environmental impact of clinical trials.

Through professional services and customization options, Medidata Oncology Solutions ensures compliance, efficiency, and quality in clinical research. By uniting innovative technologies on a single platform, it enables faster decision-making, accelerates approvals, and delivers better outcomes for sponsors, sites, and patients.